Search Results - "HABERBOSCH, Werner"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE−/− /LDL−/− double knockout mice by Langheinrich, Alexander C, Sedding, Daniel G, Kampschulte, Marian, Moritz, Regina, Wilhelm, Jochen, Haberbosch, Werner G, Ritman, Erik L, Bohle, Rainer M

    Published in Atherosclerosis (01-01-2009)
    “…Abstract Background Atherosclerosis and inflammation/angiogenesis are strongly associated including growth of vasa vasorum (VV) and plaque neovascularization,…”
    Get full text
    Journal Article
  5. 5

    The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease by Gardemann, A, Lohre, J, Katz, N, Tillmanns, H, Hehrlein, F W, Haberbosch, W

    Published in Thrombosis and haemostasis (01-09-1999)
    “…Disturbances in fibrinolytic activity, such as increase in plasminogen activator inhibitor (PAI) activity, have been linked with an increased risk for coronary…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Long-term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction by Waldecker, Bernd, Waas, Wolfgang, Haberbosch, Werner, Voss, Reinhard, Heizmann, Heinrich, Tillmanns, Harald

    “…Objectives. The purpose of this study was to analyze long-term follow-up information over several years from consecutive, unselected patients treated with…”
    Get full text
    Journal Article
  8. 8

    The factor II G20210A and factor V G1691A gene transitions and coronary heart disease by Gardemann, A, Arsic, T, Katz, N, Tillmanns, H, Hehrlein, F W, Haberbosch, W

    Published in Thrombosis and haemostasis (01-02-1999)
    “…G to A transitions at nucleotide position 20210 of the factor II (Fll) gene and at 1691 of the factor V (FV) gene have been shown to be associated with an…”
    Get more information
    Journal Article
  9. 9

    Effects of 3-deazaadenosine on homocysteine and atherosclerosis in apolipoprotein E-deficient mice by Langheinrich, Alexander Claus, Braun-Dullaeus, Ruediger Christian, Walker, Gerhard, Jeide, Ina, Schilling, Ralph, Tammoscheit, Kai, Dreyer, Thomas, Fink, Ludger, Bohle, Rainer Maria, Haberbosch, Werner

    Published in Atherosclerosis (01-12-2003)
    “…Objective: In the past decade, elevated homocysteine concentration has achieved widespread recognition as an independent risk factor in the development of…”
    Get full text
    Journal Article
  10. 10

    Low Prevalence of Chlamydia pneumoniae in Atherectomy Specimens from Patients with Coronary Heart Disease by Jantos, Christian A., Nesseler, Anne, Waas, Wolfgang, Baumgärtner, Wolfgang, Tillmanns, Harald, Haberbosch, Werner

    Published in Clinical infectious diseases (01-05-1999)
    “…Coronary atherectomy specimens from 50 patients with coronary heart disease were examined for the presence of Chlamydia pneumoniae by two different methods of…”
    Get full text
    Journal Article
  11. 11

    Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives by Hölschermann, H, Terhalle, H M, Zakel, U, Maus, U, Parviz, B, Tillmanns, H, Haberbosch, W

    Published in Thrombosis and haemostasis (01-12-1999)
    “…The association between use of oral contraceptives (OCs) and increased risk of thromboembolic disease has been firmly established. This risk increases when use…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Statins prevent NF-κB transactivation independently of the IKK-pathway in human endothelial cells by Hölschermann, Hans, Schuster, Daniel, Parviz, Behnoush, Haberbosch, Werner, Tillmanns, Harald, Muth, Heidrun

    Published in Atherosclerosis (01-04-2006)
    “…Statins have been linked to a wide range of vascular benefits, many of them are likely to be due to attenuation of chronic vascular inflammation. Nuclear…”
    Get full text
    Journal Article
  18. 18

    Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective? by Haberbosch, Werner

    Published in Herz (01-02-2007)
    “…Patients with type 2 diabetes face a high risk of cardiovascular morbidity and mortality. In these patients a whole cluster of cardiovascular risk factors is…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Study of the effectiveness of musical stimulation during intracardiac catheterization by Argstatter, Heike, Haberbosch, Werner, Bolay, Hans Volker

    Published in Clinical research in cardiology (01-10-2006)
    “…Intracardiac catheterization is a routine physical examination. Due to psychological strains, several psychosocial interventions, including music therapy, have…”
    Get full text
    Journal Article